Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR84 | Q9NQS5 | 8/20 | 0.53 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.53 |
| ▸ | HSPD1 | P10809 | 1/20 | 0.49 |
| ▸ | BLM | P54132 | 1/20 | 0.49 |
| ▸ | HSPE1 | P61604 | 1/20 | 0.49 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.48 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | LCK | P06239 | 1/20 | 0.47 |
| ▸ | PPARD | Q03181 | 1/20 | 0.47 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.47 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.47 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.44 |
| ▸ | ACACB | O00763 | 1/20 | 0.44 |
| ▸ | ACACA | Q13085 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | HPGD | P15428 | 1/20 | 0.44 |
| ▸ | RECQL | P46063 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.44 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7148025 | 1.00 | GPR84 (0.53) | GPR84FFAR1HSPD1BLMHSPE1 | |
| SCHEMBL18322324 | 1.00 | GPR84 (0.53) | GPR84FFAR1HSPD1BLMHSPE1 | |
| SCHEMBL9297272 | 1.00 | GPR84 (0.53) | GPR84FFAR1HSPD1BLMHSPE1 | |
| Ammonia Solution, Strong SCHEMBL10519337 | 0.98 | GPR84 (0.52) | GPR84FFAR1HSPD1BLMHSPE1 | |
| SCHEMBL6686309 | 0.98 | GPR84 (0.52) | GPR84FFAR1HSPD1BLMHSPE1 | |
| Ethylene Glycol SCHEMBL26926887 | 0.94 | GPR84 (0.48) | GPR84FFAR1HSPD1BLMHSPE1 | |
| Glycerin SCHEMBL158648 | 0.93 | GPR84 (0.49) | GPR84FFAR1HSPD1BLMHSPE1 | |
| Glycerin SCHEMBL76901 | 0.93 | GPR84 (0.49) | GPR84FFAR1HSPD1BLMHSPE1 | |
| SCHEMBL28356481 | 0.93 | GPR84 (0.47) | GPR84FFAR1HSPD1BLMHSPE1 | |
| SCHEMBL3299285 | 0.92 | CA2 (0.43) | GPR84FFAR1HSPD1BLMHSPE1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 783 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026046506-A1 | EVAPORATING MICROEMULSIONS | SYMRISE AG (DE) | 2026-03-05 | — | — | WO | claimed |
| WO-2026046686-A1 | EVAPORATING MICROEMULSIONS | SYMRISE AG (DE) | 2026-03-05 | — | — | WO | claimed |
| US-20250351836-A1 | SEED EXTRACT FOR USE DURING FOOD COOKING AND STORAGE PROCESSES | Khalifa University of Science and Technology (AE) | 2025-11-20 | — | — | US | claimed |
| WO-2025228622-A1 | AN ANTI-FUNGAL COMPOSITION | UNILEVER IP HOLDINGS B.V. (NL) | 2025-11-06 | — | — | WO | claimed |
| US-20250325457-A1 | TRANSPARENT DIFFUSIBLE MICROEMULSIONS | SYMRISE AG (DE) | 2025-10-23 | — | — | US | claimed |
| WO-2025108987-A1 | COMPOSITIONS AND METHODS FOR TREATING EYETEAR FILM DEFICIENCY AND REDEYE | BAUSCH + LOMB IRELAND LIMITED (IE) | 2025-05-30 | — | — | WO | claimed |
| EP-4450604-A2 | TRANSPARENT DIFFUSIBLE MICROEMULSIONS | Symrise AG (DE) | 2024-10-23 | — | — | EP | claimed |
| EP-4314195-B1 | TRANSPARENT DIFFUSIBLE MICROEMULSIONS | SYMRISE AG (DE) | 2024-09-18 | — | — | EP | claimed |
| EP-4171475-B1 | COMPOSITION COMPRISING A COMBINATION OF POLYGLYCEROL ESTERS | OREAL (FR) | 2024-06-19 | — | — | EP | claimed |
| WO-2024110503-A1 | METHODS FOR TREATING EYETEAR FILM DEFICIENCY | BAUSCH + LOMB IRELAND LIMITED (IE) | 2024-05-30 | — | — | WO | claimed |
| WO-1998047534-A1 | STABILIZED MEDICAMENTS CONTAINING CYSTEINYL DERIVATIVES | KLINGE PHARMA GMBH (DE) | 1998-10-29 | — | — | WO | claimed |
| EP-0511121-B1 | Desulfurisation agent for pig iron, comprising calcium carbide and an organic binder | PECHINEY ELECTROMETALLURGIE (FR) | 1996-09-11 | — | — | EP | claimed |
| EP-0485309-B1 | PRODUCT BASED ON COATED MAGNESIUM FOR THE DESULPHURIZING OF CAST IRON OR LIQUID STEEL | PECHINEY ELECTROMETALLURGIE (FR) | 1993-09-29 | — | — | EP | claimed |
| EP-0413171-B1 | STRONG ANALGESIC COMPOSITION AND PROCESS FOR ITS PREPARATION | Dolorgiet GmbH & Co. KG (DE) | 1993-05-26 | — | — | EP | claimed |
| EP-0511121-A1 | Desulfurisation agent for pig iron, comprising calcium carbide and an organic binder | PECHINEY ELECTROMETALLURGIE (FR) | 1992-10-28 | — | — | EP | claimed |
| EP-0485309-A1 | Product based on coated magnesium for the desulphurizing of cast iron or liquid steel | PECHINEY ELECTROMETALLURGIE (FR) | 1992-05-13 | — | — | EP | claimed |
| EP-0178436-B1 | SOFT GELATINE CAPSULES CONTAINING IBUPROFEN AND PROCESS FOR THEIR PREPARATION | Dolorgiet GmbH & Co. KG (DE) | 1990-10-24 | — | — | EP | claimed |
| EP-0240874-B1 | HIGHLY RESORBABLE PREPARATION OF HYMECROMONE, AND METHOD FOR ITS PRODUCTION | Dolorgiet GmbH & Co. KG (DE) | 1990-09-12 | — | — | EP | claimed |
| EP-0013755-B1 | BEESWAX SUBSTITUTE BASED ON GLYCERIDES OF HIGHER FATTY ACIDS AND ITS USE | Henkel Kommanditgesellschaft auf Aktien (DE) | 1983-06-22 | — | — | EP | claimed |
| US-4368116-A | Polyhydroxy fatty acids collector-frothers | PETROVICH VOJISLAV | 1983-01-11 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250325457-A1 | TRANSPARENT DIFFUSIBLE MICROEMULSIONS | TPM3, DSP, TPM4 | GPR84 1751/4885FFAR1 503/4885HSPD1 2761/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.